China Oxytocic Pharmaceuticals Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Available under the brand name of Pitocin, the drug oxytocin, which is derived from the peptide of the same name, is commonly used on women during childbirth in order to induce contractions. This can not only increase labor speeds and reduce the time taken for childbirth, but can also cease bleeding after delivery. It is almost always administered to a patient by injecting it into their vein or muscle.

    This report offers an overview of the market trends, drivers, and barriers with respect to the China Oxytocic Pharmaceuticals market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Oxytocic Pharmaceuticals market. Detailed analysis of key players, along with key growth strategies adopted by Oxytocic Pharmaceuticals industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Biofutura

    • Ferring

    • Pfizer

    • Fresenius Kaci

    • Teva

    • Baxter

    • Novartis

    By Type:

    • Natural Oxytocin

    • Synthetic Oxytocin Derivative

    By End-User:

    • Abortion Induced Incomplete

    • Inevitable Abortion

    • Post-partum Haemorrhage

    • Labour Induction

    • Labour Arrest

    By Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Oxytocic Pharmaceuticals Market

    • 1.3 Market Segment by Type

    • 1.3.1 China Oxytocic Pharmaceuticals Market Size and Growth Rate of Natural Oxytocin from 2016 to 2027

    • 1.3.2 China Oxytocic Pharmaceuticals Market Size and Growth Rate of Synthetic Oxytocin Derivative from 2016 to 2027

    • 1.4 Market Segment by Application

    • 1.4.1 China Oxytocic Pharmaceuticals Market Size and Growth Rate of Abortion Induced Incomplete from 2016 to 2027

    • 1.4.2 China Oxytocic Pharmaceuticals Market Size and Growth Rate of Inevitable Abortion from 2016 to 2027

    • 1.4.3 China Oxytocic Pharmaceuticals Market Size and Growth Rate of Post-partum Haemorrhage from 2016 to 2027

    • 1.4.4 China Oxytocic Pharmaceuticals Market Size and Growth Rate of Labour Induction from 2016 to 2027

    • 1.4.5 China Oxytocic Pharmaceuticals Market Size and Growth Rate of Labour Arrest from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 North China Oxytocic Pharmaceuticals Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 Central China Oxytocic Pharmaceuticals Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 South China Oxytocic Pharmaceuticals Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 East China Oxytocic Pharmaceuticals Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.5 Northeast China Oxytocic Pharmaceuticals Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.6 Southwest China Oxytocic Pharmaceuticals Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.7 Northwest China Oxytocic Pharmaceuticals Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Oxytocic Pharmaceuticals Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Oxytocic Pharmaceuticals by Major Types

    • 3.4.1 Market Size and Growth Rate of Natural Oxytocin

    • 3.4.2 Market Size and Growth Rate of Synthetic Oxytocin Derivative

    4 Segmentation of Oxytocic Pharmaceuticals Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Oxytocic Pharmaceuticals by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Oxytocic Pharmaceuticals in Abortion Induced Incomplete

    • 4.4.2 Market Size and Growth Rate of Oxytocic Pharmaceuticals in Inevitable Abortion

    • 4.4.3 Market Size and Growth Rate of Oxytocic Pharmaceuticals in Post-partum Haemorrhage

    • 4.4.4 Market Size and Growth Rate of Oxytocic Pharmaceuticals in Labour Induction

    • 4.4.5 Market Size and Growth Rate of Oxytocic Pharmaceuticals in Labour Arrest

    5 Market Analysis by Regions

    • 5.1 China Oxytocic Pharmaceuticals Production Analysis by Regions

    • 5.2 China Oxytocic Pharmaceuticals Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on China Economy

    6 North China Oxytocic Pharmaceuticals Landscape Analysis

    • 6.1 North China Oxytocic Pharmaceuticals Landscape Analysis by Major Types

    • 6.2 North China Oxytocic Pharmaceuticals Landscape Analysis by Major End-Users

    7 Central China Oxytocic Pharmaceuticals Landscape Analysis

    • 7.1 Central China Oxytocic Pharmaceuticals Landscape Analysis by Major Types

    • 7.2 Central China Oxytocic Pharmaceuticals Landscape Analysis by Major End-Users

    8 South China Oxytocic Pharmaceuticals Landscape Analysis

    • 8.1 South China Oxytocic Pharmaceuticals Landscape Analysis by Major Types

    • 8.2 South China Oxytocic Pharmaceuticals Landscape Analysis by Major End-Users

    9 East China Oxytocic Pharmaceuticals Landscape Analysis

    • 9.1 East China Oxytocic Pharmaceuticals Landscape Analysis by Major Types

    • 9.2 East China Oxytocic Pharmaceuticals Landscape Analysis by Major End-Users

    10 Northeast China Oxytocic Pharmaceuticals Landscape Analysis

    • 10.1 Northeast China Oxytocic Pharmaceuticals Landscape Analysis by Major Types

    • 10.2 Northeast China Oxytocic Pharmaceuticals Landscape Analysis by Major End-Users

    11 Southwest China Oxytocic Pharmaceuticals Landscape Analysis

    • 11.1 Southwest China Oxytocic Pharmaceuticals Landscape Analysis by Major Types

    • 11.2 Southwest China Oxytocic Pharmaceuticals Landscape Analysis by Major End-Users

    12 Northwest China Oxytocic Pharmaceuticals Landscape Analysis

    • 12.1 Northwest China Oxytocic Pharmaceuticals Landscape Analysis by Major Types

    • 12.2 Northwest China Oxytocic Pharmaceuticals Landscape Analysis by Major End-Users

    13 Major Players Profiles

    • 13.1 Biofutura

      • 13.1.1 Biofutura Company Profile and Recent Development

      • 13.1.2 Market Performance

      • 13.1.3 Product and Service Introduction

    • 13.2 Ferring

      • 13.2.1 Ferring Company Profile and Recent Development

      • 13.2.2 Market Performance

      • 13.2.3 Product and Service Introduction

    • 13.3 Pfizer

      • 13.3.1 Pfizer Company Profile and Recent Development

      • 13.3.2 Market Performance

      • 13.3.3 Product and Service Introduction

    • 13.4 Fresenius Kaci

      • 13.4.1 Fresenius Kaci Company Profile and Recent Development

      • 13.4.2 Market Performance

      • 13.4.3 Product and Service Introduction

    • 13.5 Teva

      • 13.5.1 Teva Company Profile and Recent Development

      • 13.5.2 Market Performance

      • 13.5.3 Product and Service Introduction

    • 13.6 Baxter

      • 13.6.1 Baxter Company Profile and Recent Development

      • 13.6.2 Market Performance

      • 13.6.3 Product and Service Introduction

    • 13.7 Novartis

      • 13.7.1 Novartis Company Profile and Recent Development

      • 13.7.2 Market Performance

      • 13.7.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure China Oxytocic Pharmaceuticals Market Size and Growth Rate of Natural Oxytocin from 2016 to 2027

    • Figure China Oxytocic Pharmaceuticals Market Size and Growth Rate of Synthetic Oxytocin Derivative from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2021

    • Figure Market Share by Type in 2027

    • Figure China Oxytocic Pharmaceuticals Market Size and Growth Rate of Abortion Induced Incomplete from 2016 to 2027

    • Figure China Oxytocic Pharmaceuticals Market Size and Growth Rate of Inevitable Abortion from 2016 to 2027

    • Figure China Oxytocic Pharmaceuticals Market Size and Growth Rate of Post-partum Haemorrhage from 2016 to 2027

    • Figure China Oxytocic Pharmaceuticals Market Size and Growth Rate of Labour Induction from 2016 to 2027

    • Figure China Oxytocic Pharmaceuticals Market Size and Growth Rate of Labour Arrest from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2021

    • Figure Market Share by End-User in 2027

    • Figure North China Oxytocic Pharmaceuticals Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Central China Oxytocic Pharmaceuticals Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South China Oxytocic Pharmaceuticals Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure East China Oxytocic Pharmaceuticals Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast China Oxytocic Pharmaceuticals Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Southwest China Oxytocic Pharmaceuticals Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northwest China Oxytocic Pharmaceuticals Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Oxytocic Pharmaceuticals Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2020

    • Figure Market Share of TOP 5 Players in 2021

    • Figure Market Share of TOP 6 Players from 2016 to 2021

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Map of China

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Oxytocic Pharmaceuticals

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Oxytocic Pharmaceuticals by Different Types from 2016 to 2027

    • Table Consumption Share of Oxytocic Pharmaceuticals by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Natural Oxytocin

    • Figure Market Size and Growth Rate of Synthetic Oxytocin Derivative

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Oxytocic Pharmaceuticals by Different End-Users from 2016 to 2027

    • Table Consumption Share of Oxytocic Pharmaceuticals by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Abortion Induced Incomplete

    • Figure Market Size and Growth Rate of Inevitable Abortion

    • Figure Market Size and Growth Rate of Post-partum Haemorrhage

    • Figure Market Size and Growth Rate of Labour Induction

    • Figure Market Size and Growth Rate of Labour Arrest

    • Table China Oxytocic Pharmaceuticals Production by Regions

    • Table China Oxytocic Pharmaceuticals Production Share by Regions

    • Figure China Oxytocic Pharmaceuticals Production Share by Regions in 2016

    • Figure China Oxytocic Pharmaceuticals Production Share by Regions in 2021

    • Figure China Oxytocic Pharmaceuticals Production Share by Regions in 2027

    • Table China Oxytocic Pharmaceuticals Consumption by Regions

    • Table China Oxytocic Pharmaceuticals Consumption Share by Regions

    • Figure China Oxytocic Pharmaceuticals Consumption Share by Regions in 2016

    • Figure China Oxytocic Pharmaceuticals Consumption Share by Regions in 2021

    • Figure China Oxytocic Pharmaceuticals Consumption Share by Regions in 2027

    • Table North China Oxytocic Pharmaceuticals Consumption by Types from 2016 to 2027

    • Table North China Oxytocic Pharmaceuticals Consumption Share by Types from 2016 to 2027

    • Figure North China Oxytocic Pharmaceuticals Consumption Share by Types in 2016

    • Figure North China Oxytocic Pharmaceuticals Consumption Share by Types in 2021

    • Figure North China Oxytocic Pharmaceuticals Consumption Share by Types in 2027

    • Table North China Oxytocic Pharmaceuticals Consumption by End-Users from 2016 to 2027

    • Table North China Oxytocic Pharmaceuticals Consumption Share by End-Users from 2016 to 2027

    • Figure North China Oxytocic Pharmaceuticals Consumption Share by End-Users in 2016

    • Figure North China Oxytocic Pharmaceuticals Consumption Share by End-Users in 2021

    • Figure North China Oxytocic Pharmaceuticals Consumption Share by End-Users in 2027

    • Table Central China Oxytocic Pharmaceuticals Consumption by Types from 2016 to 2027

    • Table Central China Oxytocic Pharmaceuticals Consumption Share by Types from 2016 to 2027

    • Figure Central China Oxytocic Pharmaceuticals Consumption Share by Types in 2016

    • Figure Central China Oxytocic Pharmaceuticals Consumption Share by Types in 2021

    • Figure Central China Oxytocic Pharmaceuticals Consumption Share by Types in 2027

    • Table Central China Oxytocic Pharmaceuticals Consumption by End-Users from 2016 to 2027

    • Table Central China Oxytocic Pharmaceuticals Consumption Share by End-Users from 2016 to 2027

    • Figure Central China Oxytocic Pharmaceuticals Consumption Share by End-Users in 2016

    • Figure Central China Oxytocic Pharmaceuticals Consumption Share by End-Users in 2021

    • Figure Central China Oxytocic Pharmaceuticals Consumption Share by End-Users in 2027

    • Table South China Oxytocic Pharmaceuticals Consumption by Types from 2016 to 2027

    • Table South China Oxytocic Pharmaceuticals Consumption Share by Types from 2016 to 2027

    • Figure South China Oxytocic Pharmaceuticals Consumption Share by Types in 2016

    • Figure South China Oxytocic Pharmaceuticals Consumption Share by Types in 2021

    • Figure South China Oxytocic Pharmaceuticals Consumption Share by Types in 2027

    • Table South China Oxytocic Pharmaceuticals Consumption by End-Users from 2016 to 2027

    • Table South China Oxytocic Pharmaceuticals Consumption Share by End-Users from 2016 to 2027

    • Figure South China Oxytocic Pharmaceuticals Consumption Share by End-Users in 2016

    • Figure South China Oxytocic Pharmaceuticals Consumption Share by End-Users in 2021

    • Figure South China Oxytocic Pharmaceuticals Consumption Share by End-Users in 2027

    • Table East China Oxytocic Pharmaceuticals Consumption by Types from 2016 to 2027

    • Table East China Oxytocic Pharmaceuticals Consumption Share by Types from 2016 to 2027

    • Figure East China Oxytocic Pharmaceuticals Consumption Share by Types in 2016

    • Figure East China Oxytocic Pharmaceuticals Consumption Share by Types in 2021

    • Figure East China Oxytocic Pharmaceuticals Consumption Share by Types in 2027

    • Table East China Oxytocic Pharmaceuticals Consumption by End-Users from 2016 to 2027

    • Table East China Oxytocic Pharmaceuticals Consumption Share by End-Users from 2016 to 2027

    • Figure East China Oxytocic Pharmaceuticals Consumption Share by End-Users in 2016

    • Figure East China Oxytocic Pharmaceuticals Consumption Share by End-Users in 2021

    • Figure East China Oxytocic Pharmaceuticals Consumption Share by End-Users in 2027

    • Table Northeast China Oxytocic Pharmaceuticals Consumption by Types from 2016 to 2027

    • Table Northeast China Oxytocic Pharmaceuticals Consumption Share by Types from 2016 to 2027

    • Figure Northeast China Oxytocic Pharmaceuticals Consumption Share by Types in 2016

    • Figure Northeast China Oxytocic Pharmaceuticals Consumption Share by Types in 2021

    • Figure Northeast China Oxytocic Pharmaceuticals Consumption Share by Types in 2027

    • Table Northeast China Oxytocic Pharmaceuticals Consumption by End-Users from 2016 to 2027

    • Table Northeast China Oxytocic Pharmaceuticals Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast China Oxytocic Pharmaceuticals Consumption Share by End-Users in 2016

    • Figure Northeast China Oxytocic Pharmaceuticals Consumption Share by End-Users in 2021

    • Figure Northeast China Oxytocic Pharmaceuticals Consumption Share by End-Users in 2027

    • Table Southwest China Oxytocic Pharmaceuticals Consumption by Types from 2016 to 2027

    • Table Southwest China Oxytocic Pharmaceuticals Consumption Share by Types from 2016 to 2027

    • Figure Southwest China Oxytocic Pharmaceuticals Consumption Share by Types in 2016

    • Figure Southwest China Oxytocic Pharmaceuticals Consumption Share by Types in 2021

    • Figure Southwest China Oxytocic Pharmaceuticals Consumption Share by Types in 2027

    • Table Southwest China Oxytocic Pharmaceuticals Consumption by End-Users from 2016 to 2027

    • Table Southwest China Oxytocic Pharmaceuticals Consumption Share by End-Users from 2016 to 2027

    • Figure Southwest China Oxytocic Pharmaceuticals Consumption Share by End-Users in 2016

    • Figure Southwest China Oxytocic Pharmaceuticals Consumption Share by End-Users in 2021

    • Figure Southwest China Oxytocic Pharmaceuticals Consumption Share by End-Users in 2027

    • Table Northwest China Oxytocic Pharmaceuticals Consumption by Types from 2016 to 2027

    • Table Northwest China Oxytocic Pharmaceuticals Consumption Share by Types from 2016 to 2027

    • Figure Northwest China Oxytocic Pharmaceuticals Consumption Share by Types in 2016

    • Figure Northwest China Oxytocic Pharmaceuticals Consumption Share by Types in 2021

    • Figure Northwest China Oxytocic Pharmaceuticals Consumption Share by Types in 2027

    • Table Northwest China Oxytocic Pharmaceuticals Consumption by End-Users from 2016 to 2027

    • Table Northwest China Oxytocic Pharmaceuticals Consumption Share by End-Users from 2016 to 2027

    • Figure Northwest China Oxytocic Pharmaceuticals Consumption Share by End-Users in 2016

    • Figure Northwest China Oxytocic Pharmaceuticals Consumption Share by End-Users in 2021

    • Figure Northwest China Oxytocic Pharmaceuticals Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Biofutura

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biofutura

    • Figure Sales and Growth Rate Analysis of Biofutura

    • Figure Revenue and Market Share Analysis of Biofutura

    • Table Product and Service Introduction of Biofutura

    • Table Company Profile and Development Status of Ferring

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ferring

    • Figure Sales and Growth Rate Analysis of Ferring

    • Figure Revenue and Market Share Analysis of Ferring

    • Table Product and Service Introduction of Ferring

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Company Profile and Development Status of Fresenius Kaci

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Fresenius Kaci

    • Figure Sales and Growth Rate Analysis of Fresenius Kaci

    • Figure Revenue and Market Share Analysis of Fresenius Kaci

    • Table Product and Service Introduction of Fresenius Kaci

    • Table Company Profile and Development Status of Teva

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva

    • Figure Sales and Growth Rate Analysis of Teva

    • Figure Revenue and Market Share Analysis of Teva

    • Table Product and Service Introduction of Teva

    • Table Company Profile and Development Status of Baxter

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Baxter

    • Figure Sales and Growth Rate Analysis of Baxter

    • Figure Revenue and Market Share Analysis of Baxter

    • Table Product and Service Introduction of Baxter

    • Table Company Profile and Development Status of Novartis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis

    • Figure Sales and Growth Rate Analysis of Novartis

    • Figure Revenue and Market Share Analysis of Novartis

    • Table Product and Service Introduction of Novartis


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.